nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—CYP2C9—brain cancer	0.457	1	CbGaD
Sildenafil—ABCC10—Etoposide—brain cancer	0.128	0.396	CbGbCtD
Sildenafil—CYP2D6—Lomustine—brain cancer	0.0464	0.144	CbGbCtD
Sildenafil—CYP2D6—Hydroxyurea—brain cancer	0.0352	0.109	CbGbCtD
Sildenafil—CYP3A4—Temozolomide—brain cancer	0.0347	0.108	CbGbCtD
Sildenafil—CYP3A4—Lomustine—brain cancer	0.0295	0.0915	CbGbCtD
Sildenafil—CYP2E1—Etoposide—brain cancer	0.0235	0.073	CbGbCtD
Sildenafil—CYP3A5—Etoposide—brain cancer	0.0183	0.0567	CbGbCtD
Sildenafil—PDE6H—pineal body—brain cancer	0.00833	0.173	CbGeAlD
Sildenafil—CYP3A4—Etoposide—brain cancer	0.00713	0.0221	CbGbCtD
Sildenafil—ADORA2A—ganglion—brain cancer	0.0025	0.0518	CbGeAlD
Sildenafil—PDE6C—head—brain cancer	0.00244	0.0505	CbGeAlD
Sildenafil—PDE5A—endothelium—brain cancer	0.00196	0.0406	CbGeAlD
Sildenafil—PDE5A—blood vessel—brain cancer	0.00181	0.0375	CbGeAlD
Sildenafil—PDE6H—endocrine gland—brain cancer	0.00145	0.0301	CbGeAlD
Sildenafil—PDE6H—head—brain cancer	0.00144	0.0298	CbGeAlD
Sildenafil—PDE6G—head—brain cancer	0.00138	0.0287	CbGeAlD
Sildenafil—PDE6H—central nervous system—brain cancer	0.00131	0.0272	CbGeAlD
Sildenafil—PDE6H—brain—brain cancer	0.00104	0.0216	CbGeAlD
Sildenafil—ADORA2A—telencephalon—brain cancer	0.000963	0.02	CbGeAlD
Sildenafil—PDE5A—telencephalon—brain cancer	0.000877	0.0182	CbGeAlD
Sildenafil—ADORA2A—gonad—brain cancer	0.000804	0.0167	CbGeAlD
Sildenafil—ABCC5—telencephalon—brain cancer	0.000802	0.0166	CbGeAlD
Sildenafil—PDE5A—gonad—brain cancer	0.000732	0.0152	CbGeAlD
Sildenafil—ADORA2A—spinal cord—brain cancer	0.000675	0.014	CbGeAlD
Sildenafil—ABCC10—telencephalon—brain cancer	0.00067	0.0139	CbGeAlD
Sildenafil—ABCC5—pituitary gland—brain cancer	0.000653	0.0135	CbGeAlD
Sildenafil—CYP3A7—endocrine gland—brain cancer	0.000653	0.0135	CbGeAlD
Sildenafil—ABCC5—medulla oblongata—brain cancer	0.00063	0.0131	CbGeAlD
Sildenafil—ADORA2A—endocrine gland—brain cancer	0.000607	0.0126	CbGeAlD
Sildenafil—ADORA2A—head—brain cancer	0.0006	0.0124	CbGeAlD
Sildenafil—ABCC5—midbrain—brain cancer	0.000576	0.0119	CbGeAlD
Sildenafil—ABCC10—gonad—brain cancer	0.000559	0.0116	CbGeAlD
Sildenafil—PDE5A—endocrine gland—brain cancer	0.000553	0.0115	CbGeAlD
Sildenafil—ADORA2A—central nervous system—brain cancer	0.000547	0.0113	CbGeAlD
Sildenafil—PDE5A—head—brain cancer	0.000546	0.0113	CbGeAlD
Sildenafil—ABCC10—pituitary gland—brain cancer	0.000546	0.0113	CbGeAlD
Sildenafil—ADORA2A—cerebellum—brain cancer	0.000535	0.0111	CbGeAlD
Sildenafil—CYP2D6—hindbrain—brain cancer	0.000529	0.011	CbGeAlD
Sildenafil—ABCC10—medulla oblongata—brain cancer	0.000527	0.0109	CbGeAlD
Sildenafil—PDE5A—central nervous system—brain cancer	0.000499	0.0103	CbGeAlD
Sildenafil—PDE5A—cerebellum—brain cancer	0.000487	0.0101	CbGeAlD
Sildenafil—ABCC10—midbrain—brain cancer	0.000481	0.00998	CbGeAlD
Sildenafil—ABCC10—spinal cord—brain cancer	0.00047	0.00974	CbGeAlD
Sildenafil—ABCC5—cerebellum—brain cancer	0.000446	0.00924	CbGeAlD
Sildenafil—ADORA2A—brain—brain cancer	0.000435	0.00901	CbGeAlD
Sildenafil—ABCC10—endocrine gland—brain cancer	0.000423	0.00877	CbGeAlD
Sildenafil—PDE5A—brain—brain cancer	0.000396	0.00821	CbGeAlD
Sildenafil—ABCC10—cerebellum—brain cancer	0.000372	0.00772	CbGeAlD
Sildenafil—ABCC5—brain—brain cancer	0.000362	0.00751	CbGeAlD
Sildenafil—ABCC4—endocrine gland—brain cancer	0.000351	0.00727	CbGeAlD
Sildenafil—ABCC4—head—brain cancer	0.000346	0.00718	CbGeAlD
Sildenafil—CYP2E1—telencephalon—brain cancer	0.00034	0.00705	CbGeAlD
Sildenafil—ABCC4—central nervous system—brain cancer	0.000316	0.00655	CbGeAlD
Sildenafil—CYP2D6—brainstem—brain cancer	0.000303	0.00629	CbGeAlD
Sildenafil—ABCC10—brain—brain cancer	0.000302	0.00627	CbGeAlD
Sildenafil—CYP2C19—endocrine gland—brain cancer	0.000292	0.00605	CbGeAlD
Sildenafil—CYP2D6—telencephalon—brain cancer	0.000269	0.00558	CbGeAlD
Sildenafil—CYP2E1—medulla oblongata—brain cancer	0.000267	0.00554	CbGeAlD
Sildenafil—Nausea—Lomustine—brain cancer	0.000251	0.00184	CcSEcCtD
Sildenafil—Hypotension—Procarbazine—brain cancer	0.000251	0.00184	CcSEcCtD
Sildenafil—ABCC4—brain—brain cancer	0.000251	0.0052	CbGeAlD
Sildenafil—Neuropathy peripheral—Temozolomide—brain cancer	0.00025	0.00183	CcSEcCtD
Sildenafil—Stomatitis—Temozolomide—brain cancer	0.000248	0.00182	CcSEcCtD
Sildenafil—Urinary tract infection—Temozolomide—brain cancer	0.000248	0.00181	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000245	0.00179	CcSEcCtD
Sildenafil—Insomnia—Procarbazine—brain cancer	0.000243	0.00178	CcSEcCtD
Sildenafil—Paraesthesia—Procarbazine—brain cancer	0.000241	0.00177	CcSEcCtD
Sildenafil—Sinusitis—Temozolomide—brain cancer	0.000239	0.00175	CcSEcCtD
Sildenafil—Somnolence—Procarbazine—brain cancer	0.000239	0.00175	CcSEcCtD
Sildenafil—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000238	0.00175	CcSEcCtD
Sildenafil—CYP2E1—spinal cord—brain cancer	0.000238	0.00494	CbGeAlD
Sildenafil—Haemoglobin—Carmustine—brain cancer	0.000238	0.00174	CcSEcCtD
Sildenafil—Haemorrhage—Carmustine—brain cancer	0.000237	0.00173	CcSEcCtD
Sildenafil—Ill-defined disorder—Hydroxyurea—brain cancer	0.000236	0.00173	CcSEcCtD
Sildenafil—Anaemia—Hydroxyurea—brain cancer	0.000235	0.00173	CcSEcCtD
Sildenafil—Hypoaesthesia—Carmustine—brain cancer	0.000235	0.00173	CcSEcCtD
Sildenafil—CYP1A1—endocrine gland—brain cancer	0.000235	0.00487	CbGeAlD
Sildenafil—Decreased appetite—Procarbazine—brain cancer	0.000234	0.00171	CcSEcCtD
Sildenafil—Alanine aminotransferase increased—Etoposide—brain cancer	0.000233	0.00171	CcSEcCtD
Sildenafil—Oedema peripheral—Carmustine—brain cancer	0.000233	0.00171	CcSEcCtD
Sildenafil—Connective tissue disorder—Carmustine—brain cancer	0.000232	0.0017	CcSEcCtD
Sildenafil—CYP1A1—head—brain cancer	0.000232	0.00481	CbGeAlD
Sildenafil—Fatigue—Procarbazine—brain cancer	0.000232	0.0017	CcSEcCtD
Sildenafil—CYP3A5—endocrine gland—brain cancer	0.00023	0.00476	CbGeAlD
Sildenafil—Haemoglobin—Temozolomide—brain cancer	0.00023	0.00168	CcSEcCtD
Sildenafil—Malaise—Hydroxyurea—brain cancer	0.00023	0.00168	CcSEcCtD
Sildenafil—Pain—Procarbazine—brain cancer	0.00023	0.00168	CcSEcCtD
Sildenafil—Constipation—Procarbazine—brain cancer	0.00023	0.00168	CcSEcCtD
Sildenafil—Haemorrhage—Temozolomide—brain cancer	0.000229	0.00168	CcSEcCtD
Sildenafil—Dysphagia—Etoposide—brain cancer	0.000229	0.00168	CcSEcCtD
Sildenafil—Leukopenia—Hydroxyurea—brain cancer	0.000228	0.00167	CcSEcCtD
Sildenafil—Visual impairment—Carmustine—brain cancer	0.000228	0.00167	CcSEcCtD
Sildenafil—Hypoaesthesia—Temozolomide—brain cancer	0.000227	0.00167	CcSEcCtD
Sildenafil—Pharyngitis—Temozolomide—brain cancer	0.000227	0.00166	CcSEcCtD
Sildenafil—CYP2C9—endocrine gland—brain cancer	0.000226	0.00469	CbGeAlD
Sildenafil—Urinary tract disorder—Temozolomide—brain cancer	0.000226	0.00165	CcSEcCtD
Sildenafil—Oedema peripheral—Temozolomide—brain cancer	0.000225	0.00165	CcSEcCtD
Sildenafil—Connective tissue disorder—Temozolomide—brain cancer	0.000225	0.00165	CcSEcCtD
Sildenafil—Urethral disorder—Temozolomide—brain cancer	0.000224	0.00164	CcSEcCtD
Sildenafil—Feeling abnormal—Procarbazine—brain cancer	0.000221	0.00162	CcSEcCtD
Sildenafil—Eye disorder—Carmustine—brain cancer	0.000221	0.00162	CcSEcCtD
Sildenafil—Convulsion—Hydroxyurea—brain cancer	0.000221	0.00162	CcSEcCtD
Sildenafil—Visual impairment—Temozolomide—brain cancer	0.00022	0.00161	CcSEcCtD
Sildenafil—Gastrointestinal pain—Procarbazine—brain cancer	0.00022	0.00161	CcSEcCtD
Sildenafil—Flushing—Carmustine—brain cancer	0.00022	0.00161	CcSEcCtD
Sildenafil—Erythema multiforme—Temozolomide—brain cancer	0.000216	0.00158	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000215	0.00158	CcSEcCtD
Sildenafil—CYP2E1—endocrine gland—brain cancer	0.000214	0.00444	CbGeAlD
Sildenafil—Discomfort—Hydroxyurea—brain cancer	0.000214	0.00157	CcSEcCtD
Sildenafil—Eye disorder—Temozolomide—brain cancer	0.000214	0.00157	CcSEcCtD
Sildenafil—Urticaria—Procarbazine—brain cancer	0.000213	0.00156	CcSEcCtD
Sildenafil—Tinnitus—Temozolomide—brain cancer	0.000213	0.00156	CcSEcCtD
Sildenafil—Abdominal pain—Procarbazine—brain cancer	0.000212	0.00156	CcSEcCtD
Sildenafil—Body temperature increased—Procarbazine—brain cancer	0.000212	0.00156	CcSEcCtD
Sildenafil—Flushing—Temozolomide—brain cancer	0.000212	0.00156	CcSEcCtD
Sildenafil—Cardiac disorder—Temozolomide—brain cancer	0.000212	0.00156	CcSEcCtD
Sildenafil—CYP1A1—central nervous system—brain cancer	0.000212	0.00439	CbGeAlD
Sildenafil—CYP2E1—head—brain cancer	0.000212	0.00439	CbGeAlD
Sildenafil—Arrhythmia—Carmustine—brain cancer	0.000211	0.00155	CcSEcCtD
Sildenafil—Alopecia—Carmustine—brain cancer	0.000209	0.00153	CcSEcCtD
Sildenafil—Oedema—Hydroxyurea—brain cancer	0.000208	0.00152	CcSEcCtD
Sildenafil—Angiopathy—Temozolomide—brain cancer	0.000207	0.00152	CcSEcCtD
Sildenafil—Mental disorder—Carmustine—brain cancer	0.000207	0.00152	CcSEcCtD
Sildenafil—Infection—Hydroxyurea—brain cancer	0.000207	0.00151	CcSEcCtD
Sildenafil—Immune system disorder—Temozolomide—brain cancer	0.000206	0.00151	CcSEcCtD
Sildenafil—Mediastinal disorder—Temozolomide—brain cancer	0.000206	0.00151	CcSEcCtD
Sildenafil—Erythema—Carmustine—brain cancer	0.000206	0.00151	CcSEcCtD
Sildenafil—Malnutrition—Carmustine—brain cancer	0.000206	0.00151	CcSEcCtD
Sildenafil—Chills—Temozolomide—brain cancer	0.000205	0.0015	CcSEcCtD
Sildenafil—Pneumonia—Etoposide—brain cancer	0.000205	0.0015	CcSEcCtD
Sildenafil—Nervous system disorder—Hydroxyurea—brain cancer	0.000204	0.00149	CcSEcCtD
Sildenafil—Infestation NOS—Etoposide—brain cancer	0.000204	0.00149	CcSEcCtD
Sildenafil—Infestation—Etoposide—brain cancer	0.000204	0.00149	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000202	0.00148	CcSEcCtD
Sildenafil—Alopecia—Temozolomide—brain cancer	0.000202	0.00148	CcSEcCtD
Sildenafil—Skin disorder—Hydroxyurea—brain cancer	0.000202	0.00148	CcSEcCtD
Sildenafil—Acute coronary syndrome—Etoposide—brain cancer	0.000201	0.00147	CcSEcCtD
Sildenafil—Renal failure—Etoposide—brain cancer	0.0002	0.00147	CcSEcCtD
Sildenafil—Mental disorder—Temozolomide—brain cancer	0.0002	0.00147	CcSEcCtD
Sildenafil—Myocardial infarction—Etoposide—brain cancer	0.0002	0.00146	CcSEcCtD
Sildenafil—Neuropathy peripheral—Etoposide—brain cancer	0.0002	0.00146	CcSEcCtD
Sildenafil—Back pain—Carmustine—brain cancer	0.000199	0.00146	CcSEcCtD
Sildenafil—Malnutrition—Temozolomide—brain cancer	0.000199	0.00146	CcSEcCtD
Sildenafil—Erythema—Temozolomide—brain cancer	0.000199	0.00146	CcSEcCtD
Sildenafil—Stomatitis—Etoposide—brain cancer	0.000199	0.00146	CcSEcCtD
Sildenafil—Anorexia—Hydroxyurea—brain cancer	0.000198	0.00145	CcSEcCtD
Sildenafil—Hypersensitivity—Procarbazine—brain cancer	0.000198	0.00145	CcSEcCtD
Sildenafil—Vision blurred—Carmustine—brain cancer	0.000194	0.00142	CcSEcCtD
Sildenafil—CYP2E1—central nervous system—brain cancer	0.000193	0.004	CbGeAlD
Sildenafil—Tremor—Carmustine—brain cancer	0.000193	0.00141	CcSEcCtD
Sildenafil—Asthenia—Procarbazine—brain cancer	0.000193	0.00141	CcSEcCtD
Sildenafil—Back pain—Temozolomide—brain cancer	0.000192	0.00141	CcSEcCtD
Sildenafil—Anaemia—Carmustine—brain cancer	0.00019	0.0014	CcSEcCtD
Sildenafil—Pruritus—Procarbazine—brain cancer	0.00019	0.00139	CcSEcCtD
Sildenafil—Agitation—Carmustine—brain cancer	0.000189	0.00139	CcSEcCtD
Sildenafil—CYP2E1—cerebellum—brain cancer	0.000189	0.00391	CbGeAlD
Sildenafil—Vision blurred—Temozolomide—brain cancer	0.000188	0.00137	CcSEcCtD
Sildenafil—Tremor—Temozolomide—brain cancer	0.000186	0.00137	CcSEcCtD
Sildenafil—Dyspnoea—Hydroxyurea—brain cancer	0.000185	0.00136	CcSEcCtD
Sildenafil—Somnolence—Hydroxyurea—brain cancer	0.000185	0.00135	CcSEcCtD
Sildenafil—Ill-defined disorder—Temozolomide—brain cancer	0.000185	0.00135	CcSEcCtD
Sildenafil—Leukopenia—Carmustine—brain cancer	0.000184	0.00135	CcSEcCtD
Sildenafil—Anaemia—Temozolomide—brain cancer	0.000184	0.00135	CcSEcCtD
Sildenafil—Diarrhoea—Procarbazine—brain cancer	0.000184	0.00135	CcSEcCtD
Sildenafil—Dyspepsia—Hydroxyurea—brain cancer	0.000183	0.00134	CcSEcCtD
Sildenafil—Agitation—Temozolomide—brain cancer	0.000183	0.00134	CcSEcCtD
Sildenafil—Hypoaesthesia—Etoposide—brain cancer	0.000182	0.00133	CcSEcCtD
Sildenafil—Decreased appetite—Hydroxyurea—brain cancer	0.000181	0.00132	CcSEcCtD
Sildenafil—Urinary tract disorder—Etoposide—brain cancer	0.000181	0.00132	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000179	0.00132	CcSEcCtD
Sildenafil—Malaise—Temozolomide—brain cancer	0.000179	0.00132	CcSEcCtD
Sildenafil—Urethral disorder—Etoposide—brain cancer	0.000179	0.00131	CcSEcCtD
Sildenafil—Fatigue—Hydroxyurea—brain cancer	0.000179	0.00131	CcSEcCtD
Sildenafil—Vertigo—Temozolomide—brain cancer	0.000179	0.00131	CcSEcCtD
Sildenafil—Convulsion—Carmustine—brain cancer	0.000178	0.00131	CcSEcCtD
Sildenafil—Leukopenia—Temozolomide—brain cancer	0.000178	0.00131	CcSEcCtD
Sildenafil—Hypertension—Carmustine—brain cancer	0.000178	0.0013	CcSEcCtD
Sildenafil—Pain—Hydroxyurea—brain cancer	0.000178	0.0013	CcSEcCtD
Sildenafil—Constipation—Hydroxyurea—brain cancer	0.000178	0.0013	CcSEcCtD
Sildenafil—Dizziness—Procarbazine—brain cancer	0.000178	0.0013	CcSEcCtD
Sildenafil—Palpitations—Temozolomide—brain cancer	0.000176	0.00129	CcSEcCtD
Sildenafil—Myalgia—Carmustine—brain cancer	0.000175	0.00129	CcSEcCtD
Sildenafil—Chest pain—Carmustine—brain cancer	0.000175	0.00129	CcSEcCtD
Sildenafil—Anxiety—Carmustine—brain cancer	0.000175	0.00128	CcSEcCtD
Sildenafil—Cough—Temozolomide—brain cancer	0.000174	0.00127	CcSEcCtD
Sildenafil—Erythema multiforme—Etoposide—brain cancer	0.000173	0.00127	CcSEcCtD
Sildenafil—CYP3A4—endocrine gland—brain cancer	0.000172	0.00358	CbGeAlD
Sildenafil—Convulsion—Temozolomide—brain cancer	0.000172	0.00126	CcSEcCtD
Sildenafil—Hypertension—Temozolomide—brain cancer	0.000172	0.00126	CcSEcCtD
Sildenafil—Feeling abnormal—Hydroxyurea—brain cancer	0.000171	0.00126	CcSEcCtD
Sildenafil—Eye disorder—Etoposide—brain cancer	0.000171	0.00125	CcSEcCtD
Sildenafil—Vomiting—Procarbazine—brain cancer	0.000171	0.00125	CcSEcCtD
Sildenafil—Flushing—Etoposide—brain cancer	0.00017	0.00124	CcSEcCtD
Sildenafil—Cardiac disorder—Etoposide—brain cancer	0.00017	0.00124	CcSEcCtD
Sildenafil—CYP2D6—endocrine gland—brain cancer	0.00017	0.00352	CbGeAlD
Sildenafil—Myalgia—Temozolomide—brain cancer	0.000169	0.00124	CcSEcCtD
Sildenafil—Arthralgia—Temozolomide—brain cancer	0.000169	0.00124	CcSEcCtD
Sildenafil—Rash—Procarbazine—brain cancer	0.000169	0.00124	CcSEcCtD
Sildenafil—Dermatitis—Procarbazine—brain cancer	0.000169	0.00124	CcSEcCtD
Sildenafil—Anxiety—Temozolomide—brain cancer	0.000169	0.00124	CcSEcCtD
Sildenafil—Headache—Procarbazine—brain cancer	0.000168	0.00123	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000168	0.00123	CcSEcCtD
Sildenafil—CYP1A1—brain—brain cancer	0.000168	0.00349	CbGeAlD
Sildenafil—Oedema—Carmustine—brain cancer	0.000168	0.00123	CcSEcCtD
Sildenafil—CYP2D6—head—brain cancer	0.000168	0.00347	CbGeAlD
Sildenafil—Discomfort—Temozolomide—brain cancer	0.000167	0.00123	CcSEcCtD
Sildenafil—Infection—Carmustine—brain cancer	0.000167	0.00122	CcSEcCtD
Sildenafil—Angiopathy—Etoposide—brain cancer	0.000166	0.00122	CcSEcCtD
Sildenafil—Dry mouth—Temozolomide—brain cancer	0.000166	0.00121	CcSEcCtD
Sildenafil—Immune system disorder—Etoposide—brain cancer	0.000165	0.00121	CcSEcCtD
Sildenafil—Mediastinal disorder—Etoposide—brain cancer	0.000165	0.00121	CcSEcCtD
Sildenafil—Body temperature increased—Hydroxyurea—brain cancer	0.000164	0.0012	CcSEcCtD
Sildenafil—Chills—Etoposide—brain cancer	0.000164	0.0012	CcSEcCtD
Sildenafil—Tachycardia—Carmustine—brain cancer	0.000164	0.0012	CcSEcCtD
Sildenafil—Oedema—Temozolomide—brain cancer	0.000162	0.00119	CcSEcCtD
Sildenafil—Alopecia—Etoposide—brain cancer	0.000162	0.00118	CcSEcCtD
Sildenafil—Infection—Temozolomide—brain cancer	0.000161	0.00118	CcSEcCtD
Sildenafil—Anorexia—Carmustine—brain cancer	0.00016	0.00117	CcSEcCtD
Sildenafil—Nausea—Procarbazine—brain cancer	0.00016	0.00117	CcSEcCtD
Sildenafil—Nervous system disorder—Temozolomide—brain cancer	0.000159	0.00117	CcSEcCtD
Sildenafil—Skin disorder—Temozolomide—brain cancer	0.000158	0.00116	CcSEcCtD
Sildenafil—Hypotension—Carmustine—brain cancer	0.000157	0.00115	CcSEcCtD
Sildenafil—Hyperhidrosis—Temozolomide—brain cancer	0.000157	0.00115	CcSEcCtD
Sildenafil—CYP3A4—central nervous system—brain cancer	0.000155	0.00322	CbGeAlD
Sildenafil—Anorexia—Temozolomide—brain cancer	0.000155	0.00113	CcSEcCtD
Sildenafil—Back pain—Etoposide—brain cancer	0.000154	0.00113	CcSEcCtD
Sildenafil—CYP2E1—brain—brain cancer	0.000153	0.00318	CbGeAlD
Sildenafil—Hypersensitivity—Hydroxyurea—brain cancer	0.000153	0.00112	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Carmustine—brain cancer	0.000153	0.00112	CcSEcCtD
Sildenafil—CYP2D6—central nervous system—brain cancer	0.000153	0.00317	CbGeAlD
Sildenafil—Insomnia—Carmustine—brain cancer	0.000152	0.00111	CcSEcCtD
Sildenafil—Paraesthesia—Carmustine—brain cancer	0.000151	0.00111	CcSEcCtD
Sildenafil—Dyspnoea—Carmustine—brain cancer	0.00015	0.0011	CcSEcCtD
Sildenafil—CYP2D6—cerebellum—brain cancer	0.000149	0.0031	CbGeAlD
Sildenafil—Somnolence—Carmustine—brain cancer	0.000149	0.0011	CcSEcCtD
Sildenafil—Asthenia—Hydroxyurea—brain cancer	0.000149	0.00109	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000148	0.00108	CcSEcCtD
Sildenafil—Ill-defined disorder—Etoposide—brain cancer	0.000148	0.00108	CcSEcCtD
Sildenafil—Anaemia—Etoposide—brain cancer	0.000147	0.00108	CcSEcCtD
Sildenafil—Insomnia—Temozolomide—brain cancer	0.000147	0.00108	CcSEcCtD
Sildenafil—Decreased appetite—Carmustine—brain cancer	0.000146	0.00107	CcSEcCtD
Sildenafil—Paraesthesia—Temozolomide—brain cancer	0.000146	0.00107	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Carmustine—brain cancer	0.000145	0.00106	CcSEcCtD
Sildenafil—Dyspnoea—Temozolomide—brain cancer	0.000145	0.00106	CcSEcCtD
Sildenafil—Somnolence—Temozolomide—brain cancer	0.000144	0.00106	CcSEcCtD
Sildenafil—Constipation—Carmustine—brain cancer	0.000144	0.00105	CcSEcCtD
Sildenafil—Pain—Carmustine—brain cancer	0.000144	0.00105	CcSEcCtD
Sildenafil—Malaise—Etoposide—brain cancer	0.000144	0.00105	CcSEcCtD
Sildenafil—Vertigo—Etoposide—brain cancer	0.000143	0.00105	CcSEcCtD
Sildenafil—Dyspepsia—Temozolomide—brain cancer	0.000143	0.00105	CcSEcCtD
Sildenafil—Leukopenia—Etoposide—brain cancer	0.000143	0.00104	CcSEcCtD
Sildenafil—Diarrhoea—Hydroxyurea—brain cancer	0.000142	0.00104	CcSEcCtD
Sildenafil—Decreased appetite—Temozolomide—brain cancer	0.000141	0.00103	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Temozolomide—brain cancer	0.00014	0.00103	CcSEcCtD
Sildenafil—Fatigue—Temozolomide—brain cancer	0.00014	0.00103	CcSEcCtD
Sildenafil—Loss of consciousness—Etoposide—brain cancer	0.00014	0.00103	CcSEcCtD
Sildenafil—Cough—Etoposide—brain cancer	0.000139	0.00102	CcSEcCtD
Sildenafil—Constipation—Temozolomide—brain cancer	0.000139	0.00102	CcSEcCtD
Sildenafil—Pain—Temozolomide—brain cancer	0.000139	0.00102	CcSEcCtD
Sildenafil—Feeling abnormal—Carmustine—brain cancer	0.000138	0.00102	CcSEcCtD
Sildenafil—Convulsion—Etoposide—brain cancer	0.000138	0.00101	CcSEcCtD
Sildenafil—Hypertension—Etoposide—brain cancer	0.000137	0.00101	CcSEcCtD
Sildenafil—Dizziness—Hydroxyurea—brain cancer	0.000137	0.00101	CcSEcCtD
Sildenafil—Gastrointestinal pain—Carmustine—brain cancer	0.000137	0.00101	CcSEcCtD
Sildenafil—Chest pain—Etoposide—brain cancer	0.000136	0.000994	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000135	0.000987	CcSEcCtD
Sildenafil—Discomfort—Etoposide—brain cancer	0.000134	0.000982	CcSEcCtD
Sildenafil—Feeling abnormal—Temozolomide—brain cancer	0.000134	0.000981	CcSEcCtD
Sildenafil—Abdominal pain—Carmustine—brain cancer	0.000133	0.000974	CcSEcCtD
Sildenafil—Body temperature increased—Carmustine—brain cancer	0.000133	0.000974	CcSEcCtD
Sildenafil—Gastrointestinal pain—Temozolomide—brain cancer	0.000133	0.000973	CcSEcCtD
Sildenafil—Vomiting—Hydroxyurea—brain cancer	0.000132	0.000969	CcSEcCtD
Sildenafil—Rash—Hydroxyurea—brain cancer	0.000131	0.000961	CcSEcCtD
Sildenafil—Dermatitis—Hydroxyurea—brain cancer	0.000131	0.00096	CcSEcCtD
Sildenafil—PDE5A—Hemostasis—TRPC6—brain cancer	0.00013	0.00362	CbGpPWpGaD
Sildenafil—Headache—Hydroxyurea—brain cancer	0.00013	0.000955	CcSEcCtD
Sildenafil—Infection—Etoposide—brain cancer	0.000129	0.000946	CcSEcCtD
Sildenafil—Urticaria—Temozolomide—brain cancer	0.000129	0.000946	CcSEcCtD
Sildenafil—ADORA2A—GPCR ligand binding—PTCH2—brain cancer	0.000129	0.00357	CbGpPWpGaD
Sildenafil—Abdominal pain—Temozolomide—brain cancer	0.000128	0.000941	CcSEcCtD
Sildenafil—Body temperature increased—Temozolomide—brain cancer	0.000128	0.000941	CcSEcCtD
Sildenafil—ABCC5—Carbohydrate metabolism—ENO2—brain cancer	0.000128	0.00356	CbGpPWpGaD
Sildenafil—Tachycardia—Etoposide—brain cancer	0.000127	0.00093	CcSEcCtD
Sildenafil—PDE6G—Disease—HES5—brain cancer	0.000126	0.00351	CbGpPWpGaD
Sildenafil—Skin disorder—Etoposide—brain cancer	0.000126	0.000925	CcSEcCtD
Sildenafil—Hyperhidrosis—Etoposide—brain cancer	0.000126	0.000921	CcSEcCtD
Sildenafil—Anorexia—Etoposide—brain cancer	0.000124	0.000908	CcSEcCtD
Sildenafil—Hypersensitivity—Carmustine—brain cancer	0.000124	0.000908	CcSEcCtD
Sildenafil—Nausea—Hydroxyurea—brain cancer	0.000123	0.000905	CcSEcCtD
Sildenafil—Hypotension—Etoposide—brain cancer	0.000121	0.00089	CcSEcCtD
Sildenafil—CYP2D6—brain—brain cancer	0.000121	0.00252	CbGeAlD
Sildenafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000121	0.00336	CbGpPWpGaD
Sildenafil—Asthenia—Carmustine—brain cancer	0.000121	0.000884	CcSEcCtD
Sildenafil—PDE6G—Signaling Pathways—DTX2—brain cancer	0.000121	0.00335	CbGpPWpGaD
Sildenafil—Hypersensitivity—Temozolomide—brain cancer	0.00012	0.000877	CcSEcCtD
Sildenafil—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000119	0.00331	CbGpPWpGaD
Sildenafil—ABCC10—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000119	0.00331	CbGpPWpGaD
Sildenafil—PDE6G—beta-catenin independent WNT signaling—CTNNB1—brain cancer	0.000119	0.0033	CbGpPWpGaD
Sildenafil—Paraesthesia—Etoposide—brain cancer	0.000117	0.000855	CcSEcCtD
Sildenafil—Asthenia—Temozolomide—brain cancer	0.000117	0.000854	CcSEcCtD
Sildenafil—Dyspnoea—Etoposide—brain cancer	0.000116	0.000849	CcSEcCtD
Sildenafil—Somnolence—Etoposide—brain cancer	0.000116	0.000847	CcSEcCtD
Sildenafil—Diarrhoea—Carmustine—brain cancer	0.000115	0.000843	CcSEcCtD
Sildenafil—Pruritus—Temozolomide—brain cancer	0.000115	0.000842	CcSEcCtD
Sildenafil—ABCC4—Hemostasis—MPL—brain cancer	0.000113	0.00314	CbGpPWpGaD
Sildenafil—Decreased appetite—Etoposide—brain cancer	0.000113	0.000828	CcSEcCtD
Sildenafil—ADORA2A—GPCR downstream signaling—OR14C36—brain cancer	0.000113	0.00313	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—OR4C12—brain cancer	0.000113	0.00313	CbGpPWpGaD
Sildenafil—CYP2E1—Biological oxidations—CYP2C9—brain cancer	0.000112	0.00312	CbGpPWpGaD
Sildenafil—Gastrointestinal disorder—Etoposide—brain cancer	0.000112	0.000822	CcSEcCtD
Sildenafil—Fatigue—Etoposide—brain cancer	0.000112	0.000821	CcSEcCtD
Sildenafil—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000112	0.00311	CbGpPWpGaD
Sildenafil—Dizziness—Carmustine—brain cancer	0.000111	0.000815	CcSEcCtD
Sildenafil—Constipation—Etoposide—brain cancer	0.000111	0.000815	CcSEcCtD
Sildenafil—Pain—Etoposide—brain cancer	0.000111	0.000815	CcSEcCtD
Sildenafil—Diarrhoea—Temozolomide—brain cancer	0.000111	0.000815	CcSEcCtD
Sildenafil—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	0.000111	0.00307	CbGpPWpGaD
Sildenafil—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.00011	0.00307	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000109	0.00303	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—S100A10—brain cancer	0.000108	0.00301	CbGpPWpGaD
Sildenafil—Dizziness—Temozolomide—brain cancer	0.000107	0.000787	CcSEcCtD
Sildenafil—Feeling abnormal—Etoposide—brain cancer	0.000107	0.000785	CcSEcCtD
Sildenafil—Vomiting—Carmustine—brain cancer	0.000107	0.000783	CcSEcCtD
Sildenafil—Gastrointestinal pain—Etoposide—brain cancer	0.000106	0.000779	CcSEcCtD
Sildenafil—Rash—Carmustine—brain cancer	0.000106	0.000777	CcSEcCtD
Sildenafil—Dermatitis—Carmustine—brain cancer	0.000106	0.000776	CcSEcCtD
Sildenafil—CYP1A1—Biological oxidations—CYP2C9—brain cancer	0.000106	0.00294	CbGpPWpGaD
Sildenafil—Headache—Carmustine—brain cancer	0.000105	0.000772	CcSEcCtD
Sildenafil—CYP1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000104	0.0029	CbGpPWpGaD
Sildenafil—Vomiting—Temozolomide—brain cancer	0.000103	0.000757	CcSEcCtD
Sildenafil—Urticaria—Etoposide—brain cancer	0.000103	0.000757	CcSEcCtD
Sildenafil—Body temperature increased—Etoposide—brain cancer	0.000103	0.000753	CcSEcCtD
Sildenafil—Abdominal pain—Etoposide—brain cancer	0.000103	0.000753	CcSEcCtD
Sildenafil—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000103	0.00285	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—OR14C36—brain cancer	0.000102	0.00285	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—OR4C12—brain cancer	0.000102	0.00285	CbGpPWpGaD
Sildenafil—Rash—Temozolomide—brain cancer	0.000102	0.000751	CcSEcCtD
Sildenafil—Dermatitis—Temozolomide—brain cancer	0.000102	0.00075	CcSEcCtD
Sildenafil—Headache—Temozolomide—brain cancer	0.000102	0.000746	CcSEcCtD
Sildenafil—Nausea—Carmustine—brain cancer	9.98e-05	0.000732	CcSEcCtD
Sildenafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	9.8e-05	0.00272	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—VAV1—brain cancer	9.77e-05	0.00271	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—TRPC6—brain cancer	9.72e-05	0.0027	CbGpPWpGaD
Sildenafil—Nausea—Temozolomide—brain cancer	9.65e-05	0.000707	CcSEcCtD
Sildenafil—Hypersensitivity—Etoposide—brain cancer	9.57e-05	0.000702	CcSEcCtD
Sildenafil—ABCC4—Fluoropyrimidine Activity—TP53—brain cancer	9.57e-05	0.00266	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—S100A10—brain cancer	9.39e-05	0.00261	CbGpPWpGaD
Sildenafil—Asthenia—Etoposide—brain cancer	9.32e-05	0.000683	CcSEcCtD
Sildenafil—ABCC5—Disease—DTX2—brain cancer	9.3e-05	0.00258	CbGpPWpGaD
Sildenafil—PDE6G—Signaling by Wnt—APC—brain cancer	9.26e-05	0.00257	CbGpPWpGaD
Sildenafil—Pruritus—Etoposide—brain cancer	9.19e-05	0.000674	CcSEcCtD
Sildenafil—PDE6G—Signaling Pathways—PTCH2—brain cancer	9.13e-05	0.00254	CbGpPWpGaD
Sildenafil—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	9.11e-05	0.00253	CbGpPWpGaD
Sildenafil—Diarrhoea—Etoposide—brain cancer	8.89e-05	0.000652	CcSEcCtD
Sildenafil—PDE6G—Signaling Pathways—HES5—brain cancer	8.85e-05	0.00246	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—VAV1—brain cancer	8.79e-05	0.00244	CbGpPWpGaD
Sildenafil—CYP2C19—Biological oxidations—CYP2C9—brain cancer	8.66e-05	0.0024	CbGpPWpGaD
Sildenafil—Dizziness—Etoposide—brain cancer	8.59e-05	0.00063	CcSEcCtD
Sildenafil—PDE6G—Signaling Pathways—STRADA—brain cancer	8.59e-05	0.00239	CbGpPWpGaD
Sildenafil—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	8.54e-05	0.00237	CbGpPWpGaD
Sildenafil—PDE6G—Disease—IDH1—brain cancer	8.5e-05	0.00236	CbGpPWpGaD
Sildenafil—Vomiting—Etoposide—brain cancer	8.26e-05	0.000606	CcSEcCtD
Sildenafil—Rash—Etoposide—brain cancer	8.19e-05	0.000601	CcSEcCtD
Sildenafil—Dermatitis—Etoposide—brain cancer	8.19e-05	0.0006	CcSEcCtD
Sildenafil—Headache—Etoposide—brain cancer	8.14e-05	0.000597	CcSEcCtD
Sildenafil—PDE6G—Disease—HEY1—brain cancer	8.06e-05	0.00224	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—SIRT1—brain cancer	7.99e-05	0.00222	CbGpPWpGaD
Sildenafil—CYP2D6—Biological oxidations—CYP2C9—brain cancer	7.96e-05	0.00221	CbGpPWpGaD
Sildenafil—PDE6G—Disease—DLL1—brain cancer	7.9e-05	0.0022	CbGpPWpGaD
Sildenafil—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	7.85e-05	0.00218	CbGpPWpGaD
Sildenafil—Nausea—Etoposide—brain cancer	7.72e-05	0.000566	CcSEcCtD
Sildenafil—ABCC4—Hemostasis—BSG—brain cancer	7.64e-05	0.00212	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—VAV1—brain cancer	7.28e-05	0.00202	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—PDGFRA—brain cancer	7.19e-05	0.002	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—ABR—brain cancer	7.17e-05	0.00199	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—GLI2—brain cancer	6.92e-05	0.00192	CbGpPWpGaD
Sildenafil—ABCC5—Disease—HES5—brain cancer	6.82e-05	0.00189	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—VAV1—brain cancer	6.76e-05	0.00188	CbGpPWpGaD
Sildenafil—PDE6G—Disease—ENO2—brain cancer	6.72e-05	0.00187	CbGpPWpGaD
Sildenafil—PDE6G—Disease—SHH—brain cancer	6.72e-05	0.00187	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—SHH—brain cancer	6.63e-05	0.00184	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PTCH2—brain cancer	6.6e-05	0.00183	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—GLI1—brain cancer	6.51e-05	0.00181	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—IRS2—brain cancer	6.32e-05	0.00175	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—RELA—brain cancer	6.3e-05	0.00175	CbGpPWpGaD
Sildenafil—PDE6G—Signaling by Wnt—CTNNB1—brain cancer	6.29e-05	0.00175	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—SMO—brain cancer	6.28e-05	0.00174	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—PTCH1—brain cancer	6.28e-05	0.00174	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—TRPC6—brain cancer	6.26e-05	0.00174	CbGpPWpGaD
Sildenafil—ABCC4—Platelet degranulation—VEGFA—brain cancer	6.23e-05	0.00173	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—PIK3CG—brain cancer	6.21e-05	0.00172	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—SUFU—brain cancer	6.17e-05	0.00171	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—OR4C12—brain cancer	6.05e-05	0.00168	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—OR14C36—brain cancer	6.05e-05	0.00168	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—CDK4—brain cancer	6.04e-05	0.00168	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—GFAP—brain cancer	5.95e-05	0.00165	CbGpPWpGaD
Sildenafil—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	5.94e-05	0.00165	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—ABR—brain cancer	5.7e-05	0.00158	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	5.67e-05	0.00157	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—HEY1—brain cancer	5.64e-05	0.00157	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—DLL1—brain cancer	5.53e-05	0.00154	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—PDGFRA—brain cancer	5.53e-05	0.00154	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—CYP2C9—brain cancer	5.26e-05	0.00146	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—CYP2C9—brain cancer	5.21e-05	0.00145	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—ABR—brain cancer	5.18e-05	0.00144	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—DTX2—brain cancer	5.15e-05	0.00143	CbGpPWpGaD
Sildenafil—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	5.13e-05	0.00143	CbGpPWpGaD
Sildenafil—PDE6G—Signaling by Wnt—MYC—brain cancer	5.09e-05	0.00141	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—TRPC6—brain cancer	5.01e-05	0.00139	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—IRS2—brain cancer	4.86e-05	0.00135	CbGpPWpGaD
Sildenafil—PDE6G—Disease—VAV1—brain cancer	4.86e-05	0.00135	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	4.82e-05	0.00134	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—SHH—brain cancer	4.71e-05	0.00131	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	4.62e-05	0.00128	CbGpPWpGaD
Sildenafil—ABCC5—Disease—IDH1—brain cancer	4.59e-05	0.00128	CbGpPWpGaD
Sildenafil—ABCC4—Ectoderm Differentiation—CTNNB1—brain cancer	4.58e-05	0.00127	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TRPC6—brain cancer	4.54e-05	0.00126	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—BSG—brain cancer	4.47e-05	0.00124	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—SMO—brain cancer	4.46e-05	0.00124	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PTCH1—brain cancer	4.46e-05	0.00124	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	4.43e-05	0.00123	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—IL2—brain cancer	4.37e-05	0.00121	CbGpPWpGaD
Sildenafil—ABCC5—Disease—HEY1—brain cancer	4.35e-05	0.00121	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—TRPC6—brain cancer	4.34e-05	0.0012	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	4.34e-05	0.0012	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	4.34e-05	0.0012	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—ERBB2—brain cancer	4.33e-05	0.0012	CbGpPWpGaD
Sildenafil—ABCC5—Disease—DLL1—brain cancer	4.27e-05	0.00119	CbGpPWpGaD
Sildenafil—PDE6G—Disease—HES1—brain cancer	4.18e-05	0.00116	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.06e-05	0.00113	CbGpPWpGaD
Sildenafil—PDE6G—Disease—PDGFRA—brain cancer	3.98e-05	0.0011	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PTCH2—brain cancer	3.9e-05	0.00108	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—IDH1—brain cancer	3.84e-05	0.00107	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HES5—brain cancer	3.78e-05	0.00105	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—VAV1—brain cancer	3.75e-05	0.00104	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—VEGFA—brain cancer	3.71e-05	0.00103	CbGpPWpGaD
Sildenafil—ABCC4—Ectoderm Differentiation—MYC—brain cancer	3.71e-05	0.00103	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—STRADA—brain cancer	3.67e-05	0.00102	CbGpPWpGaD
Sildenafil—ABCC5—Disease—SHH—brain cancer	3.63e-05	0.00101	CbGpPWpGaD
Sildenafil—ABCC5—Disease—ENO2—brain cancer	3.63e-05	0.00101	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—TRPC6—brain cancer	3.61e-05	0.001	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—NOTCH2—brain cancer	3.57e-05	0.000991	CbGpPWpGaD
Sildenafil—PDE6G—Disease—IRS2—brain cancer	3.49e-05	0.00097	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—SHH—brain cancer	3.4e-05	0.000944	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—VAV1—brain cancer	3.4e-05	0.000944	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—RELA—brain cancer	3.35e-05	0.000931	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—ERBB2—brain cancer	3.33e-05	0.000925	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.32e-05	0.000923	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—brain cancer	3.3e-05	0.000917	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—TRPC6—brain cancer	3.28e-05	0.000911	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—IL2—brain cancer	3.25e-05	0.000904	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—SMO—brain cancer	3.22e-05	0.000895	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PTCH1—brain cancer	3.22e-05	0.000895	CbGpPWpGaD
Sildenafil—PDE6G—Disease—APC—brain cancer	3.08e-05	0.000856	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ABR—brain cancer	3.06e-05	0.00085	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—ENO2—brain cancer	3.04e-05	0.000844	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—brain cancer	3e-05	0.000834	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.97e-05	0.000825	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—GLI2—brain cancer	2.96e-05	0.000821	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—HES1—brain cancer	2.92e-05	0.000812	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—TP53—brain cancer	2.8e-05	0.000779	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PDGFRA—brain cancer	2.78e-05	0.000773	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—GLI1—brain cancer	2.78e-05	0.000772	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—brain cancer	2.77e-05	0.000768	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—VAV1—brain cancer	2.71e-05	0.000751	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—SPP1—brain cancer	2.7e-05	0.000751	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CYP2C9—brain cancer	2.65e-05	0.000736	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SUFU—brain cancer	2.63e-05	0.000732	CbGpPWpGaD
Sildenafil—ABCC5—Disease—VAV1—brain cancer	2.62e-05	0.000728	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—TP53—brain cancer	2.57e-05	0.000714	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—GFAP—brain cancer	2.54e-05	0.000706	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—STAT3—brain cancer	2.54e-05	0.000706	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—VAV1—brain cancer	2.46e-05	0.000682	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—IRS2—brain cancer	2.44e-05	0.000679	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.43e-05	0.000675	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HEY1—brain cancer	2.41e-05	0.000669	CbGpPWpGaD
Sildenafil—PDE6G—Disease—ERBB2—brain cancer	2.39e-05	0.000665	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—PIK3CG—brain cancer	2.38e-05	0.000662	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—DLL1—brain cancer	2.36e-05	0.000656	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—EGFR—brain cancer	2.31e-05	0.000641	CbGpPWpGaD
Sildenafil—ABCC5—Disease—HES1—brain cancer	2.25e-05	0.000626	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—BSG—brain cancer	2.25e-05	0.000626	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.22e-05	0.000616	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PIK3CG—brain cancer	2.16e-05	0.0006	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—APC—brain cancer	2.16e-05	0.0006	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PDGFRA—brain cancer	2.15e-05	0.000596	CbGpPWpGaD
Sildenafil—PDE6G—Disease—CTNNB1—brain cancer	2.09e-05	0.000582	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SHH—brain cancer	2.01e-05	0.000558	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—IDH1—brain cancer	1.94e-05	0.000538	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TRPC6—brain cancer	1.94e-05	0.000538	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP2C9—brain cancer	1.92e-05	0.000533	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP2C9—brain cancer	1.92e-05	0.000532	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SMO—brain cancer	1.9e-05	0.000529	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PTCH1—brain cancer	1.9e-05	0.000529	CbGpPWpGaD
Sildenafil—ABCC5—Disease—IRS2—brain cancer	1.88e-05	0.000524	CbGpPWpGaD
Sildenafil—PDE6G—Disease—STAT3—brain cancer	1.83e-05	0.000507	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP2C9—brain cancer	1.81e-05	0.000503	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—PIK3CG—brain cancer	1.72e-05	0.000477	CbGpPWpGaD
Sildenafil—PDE6G—Disease—MYC—brain cancer	1.7e-05	0.000471	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—RELA—brain cancer	1.69e-05	0.000469	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—IL2—brain cancer	1.68e-05	0.000466	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—ERBB2—brain cancer	1.68e-05	0.000466	CbGpPWpGaD
Sildenafil—ABCC5—Disease—APC—brain cancer	1.66e-05	0.000462	CbGpPWpGaD
Sildenafil—PDE6G—Disease—EGFR—brain cancer	1.66e-05	0.000461	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—BSG—brain cancer	1.63e-05	0.000453	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—BSG—brain cancer	1.63e-05	0.000452	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PIK3CG—brain cancer	1.56e-05	0.000433	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—BSG—brain cancer	1.54e-05	0.000427	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ENO2—brain cancer	1.53e-05	0.000425	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NOTCH2—brain cancer	1.52e-05	0.000423	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—IL2—brain cancer	1.52e-05	0.000422	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CCND1—brain cancer	1.48e-05	0.000411	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP2C9—brain cancer	1.48e-05	0.000411	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CTNNB1—brain cancer	1.47e-05	0.000407	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—VAV1—brain cancer	1.45e-05	0.000403	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—VEGFA—brain cancer	1.43e-05	0.000396	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—IDH1—brain cancer	1.4e-05	0.00039	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—IDH1—brain cancer	1.4e-05	0.000389	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PIK3CG—brain cancer	1.39e-05	0.000387	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP2C9—brain cancer	1.36e-05	0.000378	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—IDH1—brain cancer	1.32e-05	0.000367	CbGpPWpGaD
Sildenafil—ABCC5—Disease—ERBB2—brain cancer	1.29e-05	0.000359	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—VEGFA—brain cancer	1.29e-05	0.000359	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—STAT3—brain cancer	1.28e-05	0.000355	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—BSG—brain cancer	1.26e-05	0.00035	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HES1—brain cancer	1.25e-05	0.000347	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—IL2—brain cancer	1.21e-05	0.000336	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PDGFRA—brain cancer	1.19e-05	0.00033	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MYC—brain cancer	1.19e-05	0.00033	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—EGFR—brain cancer	1.16e-05	0.000323	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—BSG—brain cancer	1.16e-05	0.000322	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SPP1—brain cancer	1.15e-05	0.00032	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—BSG—brain cancer	1.15e-05	0.000319	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CTNNB1—brain cancer	1.13e-05	0.000314	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ENO2—brain cancer	1.11e-05	0.000308	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ENO2—brain cancer	1.11e-05	0.000307	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—IL2—brain cancer	1.1e-05	0.000305	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—IDH1—brain cancer	1.08e-05	0.000301	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.08e-05	0.000299	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—TP53—brain cancer	1.08e-05	0.000299	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ENO2—brain cancer	1.05e-05	0.00029	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IRS2—brain cancer	1.04e-05	0.00029	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—IDH1—brain cancer	9.96e-06	0.000277	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—IDH1—brain cancer	9.87e-06	0.000274	CbGpPWpGaD
Sildenafil—ABCC5—Disease—STAT3—brain cancer	9.86e-06	0.000274	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TP53—brain cancer	9.76e-06	0.000271	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CG—brain cancer	9.22e-06	0.000256	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—APC—brain cancer	9.22e-06	0.000256	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MYC—brain cancer	9.16e-06	0.000254	CbGpPWpGaD
Sildenafil—ABCC5—Disease—EGFR—brain cancer	8.96e-06	0.000249	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP2C9—brain cancer	8.9e-06	0.000247	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.81e-06	0.000245	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ENO2—brain cancer	8.56e-06	0.000238	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—EGFR—brain cancer	8.4e-06	0.000233	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.04e-06	0.000223	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ENO2—brain cancer	7.87e-06	0.000219	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ENO2—brain cancer	7.8e-06	0.000217	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—BSG—brain cancer	7.57e-06	0.00021	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—RELA—brain cancer	7.2e-06	0.0002	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ERBB2—brain cancer	7.16e-06	0.000199	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CG—brain cancer	7.02e-06	0.000195	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—IDH1—brain cancer	6.51e-06	0.000181	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL2—brain cancer	6.48e-06	0.00018	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCND1—brain cancer	6.32e-06	0.000176	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CTNNB1—brain cancer	6.26e-06	0.000174	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—VEGFA—brain cancer	5.51e-06	0.000153	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—STAT3—brain cancer	5.46e-06	0.000152	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ENO2—brain cancer	5.15e-06	0.000143	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CG—brain cancer	5.09e-06	0.000141	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CG—brain cancer	5.08e-06	0.000141	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MYC—brain cancer	5.07e-06	0.000141	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EGFR—brain cancer	4.96e-06	0.000138	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CG—brain cancer	4.8e-06	0.000133	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TP53—brain cancer	4.16e-06	0.000116	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CG—brain cancer	3.93e-06	0.000109	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CG—brain cancer	3.61e-06	0.0001	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CG—brain cancer	3.58e-06	9.94e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CG—brain cancer	2.36e-06	6.56e-05	CbGpPWpGaD
